Transmucosal Buprenorphine
INDV-6000-401
Approved small_molecule completed
Quick answer
Transmucosal Buprenorphine for Moderate to Severe Opioid-use Disorder is a Approved program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Moderate to Severe Opioid-use Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed